GALASSO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 3.958
AS - Asia 1.617
EU - Europa 1.047
SA - Sud America 228
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 24
OC - Oceania 1
Totale 6.948
Nazione #
US - Stati Uniti d'America 3.826
SG - Singapore 604
CN - Cina 376
IT - Italia 234
PL - Polonia 233
VN - Vietnam 206
BR - Brasile 167
DE - Germania 132
HK - Hong Kong 115
GB - Regno Unito 105
UA - Ucraina 95
TR - Turchia 70
BD - Bangladesh 64
CA - Canada 55
FI - Finlandia 52
IN - India 48
RU - Federazione Russa 45
FR - Francia 42
SE - Svezia 40
JP - Giappone 37
MX - Messico 36
ID - Indonesia 32
ES - Italia 17
CO - Colombia 16
AR - Argentina 15
SA - Arabia Saudita 12
BE - Belgio 11
NL - Olanda 9
NI - Nicaragua 8
PK - Pakistan 8
ZA - Sudafrica 8
CL - Cile 7
IQ - Iraq 7
CR - Costa Rica 6
UZ - Uzbekistan 6
VE - Venezuela 6
EC - Ecuador 5
HN - Honduras 5
LT - Lituania 5
MA - Marocco 5
MY - Malesia 5
PY - Paraguay 5
SV - El Salvador 5
AT - Austria 4
CZ - Repubblica Ceca 4
JO - Giordania 4
PH - Filippine 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
GT - Guatemala 3
IL - Israele 3
JM - Giamaica 3
KR - Corea 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BM - Bermuda 2
EE - Estonia 2
ET - Etiopia 2
GP - Guadalupe 2
GR - Grecia 2
HU - Ungheria 2
KZ - Kazakistan 2
MD - Moldavia 2
PE - Perù 2
PT - Portogallo 2
TN - Tunisia 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GY - Guiana 1
IE - Irlanda 1
IR - Iran 1
KE - Kenya 1
LB - Libano 1
MQ - Martinica 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.877
Città #
Ashburn 455
Fairfield 396
Singapore 383
Woodbridge 298
San Jose 259
Warsaw 233
Houston 179
Chandler 164
Beijing 139
Seattle 131
Santa Clara 130
Ann Arbor 129
Wilmington 126
Cambridge 123
Council Bluffs 120
Hong Kong 111
Jacksonville 108
Ho Chi Minh City 72
Los Angeles 70
Ferrara 62
New York 57
Hanoi 52
Dallas 47
Milan 43
Izmir 39
Munich 38
Tokyo 35
Addison 33
Nanjing 33
Princeton 32
Shanghai 30
Dearborn 26
Jakarta 26
San Diego 26
Buffalo 24
Helsinki 23
Lauterbourg 23
Bremen 22
Boardman 21
Orem 19
London 17
Phoenix 17
Atlanta 16
Montreal 16
São Paulo 16
Brooklyn 15
Toronto 14
Boston 13
Dong Ket 13
Mexico City 13
Frankfurt am Main 12
Rome 12
The Dalles 12
Brussels 11
Chennai 11
Mumbai 11
Nanchang 11
Chicago 10
Ankara 9
Columbus 9
Da Nang 9
Manchester 9
Poplar 9
Turku 9
Managua 8
Shenyang 8
Springfield 8
Stockholm 8
Cagliari 7
City of London 7
Denver 7
Bologna 6
Brasília 6
Changsha 6
Hefei 6
Jinan 6
Medina 6
Moscow 6
Orange 6
Rio de Janeiro 6
Tianjin 6
Washington 6
Auburn Hills 5
Bến Tre 5
Falls Church 5
Guangzhou 5
Jiaxing 5
Johannesburg 5
Mountain View 5
San Francisco 5
San Salvador 5
Tashkent 5
Zhengzhou 5
Amman 4
Amsterdam 4
Augusta 4
Belo Horizonte 4
Casalecchio Di Reno 4
Curitiba 4
Des Moines 4
Totale 4.833
Nome #
A systems biology approach to non-coding RNAs: the networks of cancer 337
Loss of miR-204 expression is a key event in melanoma 300
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 296
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 288
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 280
A miRNA signature for defining aggressive phenotype and prognosis in gliomas 276
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 268
MicroRNA Expression Signatures in Solid Malignancies 264
Association between idiopathic hearing loss and mitochondrial DNA mutations: a study on 169 hearing-impaired subjects 251
Identification of microRNA activity by Targets' Reverse EXpression. 246
Reprogramming of miRNA networks in cancer and leukemia 245
Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma 242
Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status 238
GAMES identifies and annotates mutations in next-generation sequencing projects 236
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants 226
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 224
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study 221
Risk factors associated with relapse of eyelid basal cell carcinoma: results from a retrospective study of 142 patients 221
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 219
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 214
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology 182
MiR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model 180
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 180
A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma 173
Deregulated microRNAs in breast ductal carcinoma in situ (DCIS) with invasive propensity 148
null 132
Blood to skin recirculation of CD4+ memory T cells associates with cutaneous and systemic manifestations of psoriatic disease 132
Pluripotent stem cell miRNAs and metastasis in invasive breast cancer. 131
Next generation analysis of breast cancer genomes for precision medicine. 121
null 119
Non-coding RNAs: a key to future personalized molecular therapy? 101
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis 90
null 87
null 80
Totale 6.948
Categoria #
all - tutte 29.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.393


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022229 0 0 0 0 15 17 19 7 10 41 27 93
2022/2023359 30 15 21 49 65 49 29 31 43 6 15 6
2023/2024173 20 21 3 3 4 29 21 19 6 2 4 41
2024/2025771 19 28 66 31 112 75 22 27 150 63 109 69
2025/20262.383 230 91 162 293 375 142 313 125 244 207 144 57
2026/2027590 50 135 170 205 30 0 0 0 0 0 0 0
Totale 6.948